| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/19/2001 | US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/19/2001 | US20010008888 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 07/19/2001 | DE10001166A1 Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung Fused pyrrole compounds, pharmaceutical compositions containing them and their use |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396996A1 Genetically modified fibroblast cell |
| 07/19/2001 | CA2396962A1 Benzosulfones and related compositions and methods |
| 07/19/2001 | CA2396413A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2396235A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | CA2396199A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | CA2396098A1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/19/2001 | CA2393597A1 Indole derivatives as mcp-1 receptor antagonists |
| 07/19/2001 | CA2393592A1 Indole derivatives as mcp-1 receptor antagonists |
| 07/19/2001 | CA2383158A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance |
| 07/19/2001 | CA2366621A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/18/2001 | EP1116725A1 Process for obtaining 17beta-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids |
| 07/18/2001 | EP1116516A1 Templating of solid particles by polymer multilayers |
| 07/18/2001 | EP1116487A2 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery |
| 07/18/2001 | EP1116028A1 Ndp |
| 07/18/2001 | EP1116027A1 Identifying agents that alter mitochondrial permeability transition pores |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115871A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 07/18/2001 | EP1115861A2 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115859A2 Hairpin hybridizer molecules for modulation of gene expression |
| 07/18/2001 | EP1115857A1 Use of specific hybrid promoters for controlling tissue expression |
| 07/18/2001 | EP1115741A2 Stereoselective process for enalapril |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115733A1 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/18/2001 | EP1115729A1 Phosphonic acid derivatives as inhibitors of ptp-1b |
| 07/18/2001 | EP1115721A1 Pyrimidone derivatives |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115718A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 07/18/2001 | EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 07/18/2001 | EP1115704A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
| 07/18/2001 | EP1115703A1 Cyclic ester or amide derivatives |
| 07/18/2001 | EP1115702A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115694A1 Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 07/18/2001 | EP1115428A1 Cationic compounds and their use as macro molecular carriers |
| 07/18/2001 | EP1115416A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 07/18/2001 | EP1115414A2 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 07/18/2001 | EP1115412A1 Neuroimmunophilins for selective neuronal radioprotection |
| 07/18/2001 | EP1115409A1 Composition for extending post meal satiety |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | EP1115404A1 Use of prostanoid antagonists for the treatment of primary headache disorders |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115397A1 Method of mitigating the adverse effects of interleukin-2 |
| 07/18/2001 | EP1115395A1 ACTIVE ENANTIOMER OF RARgamma-SPECIFIC AGONIST |
| 07/18/2001 | EP1115394A2 Pharmaceutical compositions comprising derivatives of sulphur acids |
| 07/18/2001 | EP1115393A1 Sulfonamide derivatives |
| 07/18/2001 | EP1115391A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP1115289A2 Environmentally benign crop protection agents |
| 07/18/2001 | EP1115285A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 07/18/2001 | EP1115284A1 Antifouling agents |
| 07/18/2001 | EP1034171B1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | EP0754048B1 Treatment of partial growth hormone insensitivity syndrome |
| 07/18/2001 | EP0700288B1 Inhibition of hair growth |
| 07/18/2001 | EP0607122B1 Veterinary treatment |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304449A Novel angiotensin receptor, production and use thereof |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304411A Acetylcholine enhancers |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304401A Calcilytic compounds |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1304397A Hyperforin derivatives, the use thereof and formulations containing them |
| 07/18/2001 | CN1304322A Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 07/18/2001 | CN1304319A Cervical ripening agent and cervical ripening method |
| 07/18/2001 | CN1304318A Prostaglandin EP4 receptor agonist and treatment method |
| 07/18/2001 | CN1304316A Adenovirus vector containing heterologous peptide epitope in HI loop of fiber knob |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1304306A Method for inhibiting MRP1 |
| 07/18/2001 | CN1303709A Cannulation implanted medicine and its preparation method |
| 07/18/2001 | CN1303682A Preparation method of medicine for curing surgical diseases of traditional Chinese medicine |
| 07/18/2001 | CN1068588C 1H-indole-3-acetamide splA2 inhibitors |
| 07/18/2001 | CN1068586C Crystalline polymorphic form of (S.S.S)-N-(1-[2-carboxy-3-(N2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl) throsine |
| 07/18/2001 | CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 07/18/2001 | CA2332169A1 Treatments for obesity and methods for identifiying compounds useful for treating obesity |
| 07/18/2001 | CA2296997A1 Treatment of congestive heart failure |
| 07/17/2001 | US6262282 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 07/17/2001 | US6262271 ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins |
| 07/17/2001 | US6262267 Has gonadotropin-releasing hormone antagonizing activity; useful for preventing or treating sex hormone-dependent diseases, e,g., sex hormone-dependent cancers e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |